Lenny
@pommerollelenny
Followers
71
Following
416
Statuses
69
Postdoctoral Fellow at the NIH/NIAAA. PhD from Université de Bourgogne Franche-Comté. Major interest in pulmonary fibrosis and alcohol-induced lung injury
Maryland, USA
Joined February 2020
I am honored to have been selected for the @AJRCMB Editorial Apprenticeship Program! Over the next two years, I look forward to gaining valuable hands-on experience in the editorial process of this prestigious journal. Excited for this incredible learning opportunity !
🏆 Congratulations to our 2025 editor apprentices!
1
0
3
RT @NIAAAnews: Meet Lenny Pommerolle, Ph.D., @pommerollelenny, a postdoc in NIAAA’s Section on Fibrotic Disorders, is studying the biologic…
0
3
0
Time for poster session @ICLAF_2024. Come to visit mine in the Metabolomics session PP089. We will talk about the role of GPR132 in fibrotic lung disease
0
1
9
0
0
0
0
0
0
Thanks @NIAAAnews to highlight my work made in @resatcinar lab
Study by @IRPatNIH scientists in #NIAAA's intramural program sheds light on gender-specific mechanisms by which chronic alcohol exposure affects lung immunity—and finds differences between males and females. Read the article here:
0
0
5
RT @resatcinar: @pommerollelenny will present our recent work @NIAAAnews on how chronic alcohol consumption induces sexually dimorphic and…
0
1
0
@tony_jourdan1 @AJRCMB @resatcinar @EuroRespSoc It looks like I created a new biological phenomenon “immunesysregation” 😂 Of course it should be immune dysregulation !
0
0
0
RT @ThoraxBMJ: CD206+ macrophages are relevant non-invasive imaging biomarkers and therapeutic targets in experimental lung fibrosis @LBizi…
0
3
0
I am truly honored to represent the National Institute on Alcohol Abuse and Alcoholism (NIAAA) and be rewarded of the FARE 2025. A warm thank you to my PI and mentor @resatcinar who has trusted in me now for 2 years. @IRPatNIH @NIH #SFDlab
We’re honored to announce the NIAAA winners of the NIH Fellows Award for Research Excellence (FARE) 2025. Join us in celebrating their hard work, dedication, and contributions to advancing science.
0
0
4
This work could not have been done without @PSBellaye @CGFL and my supervisor Philippe Bonniaud and Francoise Goirand @CHUDijon @Univ_BFC . Additional acknowledgments to @burgy_olivier , @CarmenGarrido, @LucileDondaine @NicolasPernet @ImaFlow @GuillaumeBeltramo.
0
0
0
🔥CD206 imaging by 99mTc-tilmanocept reprensents an outstanding tool to select patients with high CD206 cell infilftration in the lungs to lead them with an anti-CD206 therapy, including the new potent drug tofacitinib and to assess the efficacy of existing antifibrotic treatment
0
0
2
✨CD206-targeted imaging with the radiopharmaceutical 99mTc-tilmanocept represents a non-invasive imaging tool able to monitor nintedanib and tofacitinib efficacy
0
0
0
✨The imaging of CD206 appears as a relevant target in #pulmonaryfibrosis ✨The JAKinib tofacitinib, reduces bleomycin-induced lung fibrosis by reducing the pool of CD206-expressing macrophages, and turns out to be a promising treatment to #cureIPF
0
0
0